| |
Index diagnosis
|
|---|
|
Variables
|
All ALD-related costs1
|
Decompensated cirrhosis
|
Hepatocellular carcinoma
|
P-value2
|
|---|
|
N
|
1193
|
1098
|
73
| |
|
Inpatient
| | | | |
|
Mean (SD)
|
$1,272 ($2,926)
|
$1,242 ($2,806)
|
$2,093 ($4,539)
|
0.624
|
|
Median
|
$0
|
$0
|
$0
| |
|
IQR
|
$0-$1,006
|
$0-$1,056
|
$0-$1,155
| |
|
Outpatient
| | | | |
|
Mean (SD)
|
$83 ($184)
|
$76 ($168)
|
$202 ($341)
|
0.051
|
|
Median
|
$23
|
$23
|
$37
| |
|
IQR
|
$6-$79
|
$7-$78
|
$8-$157
| |
|
Other costs3
| | | | |
|
Mean (SD)
|
$1 ($11)
|
$1 ($11)
|
$2 ($10)
|
<.001
|
|
Median
|
$0
|
$0
|
$0
| |
|
IQR
|
$0-$0
|
$0-$0
|
$0-$0
| |
|
Total costs4
| | | | |
|
Mean (SD)
|
$1,356 ($2,981)
|
$1,319 ($2,848)
|
$2,297 ($4,700)
|
0.807
|
|
Median
|
$88
|
$96
|
$67
| |
- Source: Florida Medicaid database: claims with dates of service between July 1, 1998 and June 30, 2008.
- Notes: All costs are inflated to 2009 USD using the Medical Care component of the CPI. Costs over the entire follow-up period were divided by the number of eligible patient months to create the PPPM cost estimates.
-
1 “ALD-Related Costs” includes all patients with HCV and ALD, including 22 patients whose index ALD diagnosis was a transplant procedure or history of transplant.
-
2 Calculated with the Wilcoxon test for comparison of means.
-
3 "Other" costs include nursing home, home health, hospice, and other services.
-
4 "Total costs" include inpatient, outpatient, pharmacy, and other (nursing home, home health, hospice, and other services) costs. Pharmacy and other costs comprised < $5 of mean total ALD-related costs in each cohort.
-
ALD advanced liver disease, HCV hepatitis C virus, PPPM per-patient-per-month.
